472 related articles for article (PubMed ID: 26335571)
1. Dual Opposing Roles of Metallothionein Overexpression in C57BL/6J Mouse Pancreatic β-Cells.
Chen S; Han J; Liu Y
PLoS One; 2015; 10(9):e0137583. PubMed ID: 26335571
[TBL] [Abstract][Full Text] [Related]
2. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC
Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of metallothionein in pancreatic beta-cells reduces streptozotocin-induced DNA damage and diabetes.
Chen H; Carlson EC; Pellet L; Moritz JT; Epstein PN
Diabetes; 2001 Sep; 50(9):2040-6. PubMed ID: 11522669
[TBL] [Abstract][Full Text] [Related]
4. Metallothionein and catalase sensitize to diabetes in nonobese diabetic mice: reactive oxygen species may have a protective role in pancreatic beta-cells.
Li X; Chen H; Epstein PN
Diabetes; 2006 Jun; 55(6):1592-604. PubMed ID: 16731821
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulation of cell-penetrating tat-metallothionein for successful outcome of xenotransplanted pancreatic islet.
Kim MJ; Hwang YH; Kim YH; Lee DY
J Drug Target; 2017 Apr; 25(4):350-359. PubMed ID: 27829285
[TBL] [Abstract][Full Text] [Related]
6. Metallothionein protects islets from hypoxia and extends islet graft survival by scavenging most kinds of reactive oxygen species.
Li X; Chen H; Epstein PN
J Biol Chem; 2004 Jan; 279(1):765-71. PubMed ID: 14576162
[TBL] [Abstract][Full Text] [Related]
7. The combination of metallothionein and superoxide dismutase protects pancreatic β cells from oxidative damage.
Park L; Min D; Kim H; Park J; Choi S; Park Y
Diabetes Metab Res Rev; 2011 Nov; 27(8):802-8. PubMed ID: 22069263
[TBL] [Abstract][Full Text] [Related]
8. A general and islet cell-enriched overexpression of IGF-I results in normal islet cell growth, hypoglycemia, and significant resistance to experimental diabetes.
Robertson K; Lu Y; De Jesus K; Li B; Su Q; Lund PK; Liu JL
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E928-38. PubMed ID: 18270301
[TBL] [Abstract][Full Text] [Related]
9. The orphan nuclear receptor small heterodimer partner negatively regulates pancreatic beta cell survival and hyperglycemia in multiple low-dose streptozotocin-induced type 1 diabetic mice.
Noh JR; Hwang JH; Kim YH; Kim KS; Gang GT; Kim SW; Kim DK; Shong M; Lee IK; Choi HS; Lee CH
Int J Biochem Cell Biol; 2013 Aug; 45(8):1538-45. PubMed ID: 23680671
[TBL] [Abstract][Full Text] [Related]
10. Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy.
Cai L; Wang Y; Zhou G; Chen T; Song Y; Li X; Kang YJ
J Am Coll Cardiol; 2006 Oct; 48(8):1688-97. PubMed ID: 17045908
[TBL] [Abstract][Full Text] [Related]
11. Both conditional ablation and overexpression of E2 SUMO-conjugating enzyme (UBC9) in mouse pancreatic beta cells result in impaired beta cell function.
He X; Lai Q; Chen C; Li N; Sun F; Huang W; Zhang S; Yu Q; Yang P; Xiong F; Chen Z; Gong Q; Ren B; Weng J; Eizirik DL; Zhou Z; Wang CY
Diabetologia; 2018 Apr; 61(4):881-895. PubMed ID: 29299635
[TBL] [Abstract][Full Text] [Related]
12. NOX2 deficiency protects against streptozotocin-induced beta-cell destruction and development of diabetes in mice.
Xiang FL; Lu X; Strutt B; Hill DJ; Feng Q
Diabetes; 2010 Oct; 59(10):2603-11. PubMed ID: 20627937
[TBL] [Abstract][Full Text] [Related]
13. Glucose homeostasis, insulin secretion, and islet phospholipids in mice that overexpress iPLA2beta in pancreatic beta-cells and in iPLA2beta-null mice.
Bao S; Jacobson DA; Wohltmann M; Bohrer A; Jin W; Philipson LH; Turk J
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E217-29. PubMed ID: 17895289
[TBL] [Abstract][Full Text] [Related]
14. Tat-enhanced delivery of metallothionein can partially prevent the development of diabetes.
Park L; Min D; Kim H; Chung HY; Lee CH; Park IS; Kim Y; Park Y
Free Radic Biol Med; 2011 Nov; 51(9):1666-74. PubMed ID: 21843632
[TBL] [Abstract][Full Text] [Related]
15. Glycine Transporter-1 and glycine receptor mediate the antioxidant effect of glycine in diabetic rat islets and INS-1 cells.
Chen L; Zhang J; Li C; Wang Z; Li J; Zhao D; Wang S; Zhang H; Huang Y; Guo X
Free Radic Biol Med; 2018 Aug; 123():53-61. PubMed ID: 29753073
[TBL] [Abstract][Full Text] [Related]
16. Metallothionein deficiency exacerbates diabetic nephropathy in streptozotocin-induced diabetic mice.
Tachibana H; Ogawa D; Sogawa N; Asanuma M; Miyazaki I; Terami N; Hatanaka T; Horiguchi CS; Nakatsuka A; Eguchi J; Wada J; Yamada H; Takei K; Makino H
Am J Physiol Renal Physiol; 2014 Jan; 306(1):F105-15. PubMed ID: 24154695
[TBL] [Abstract][Full Text] [Related]
17. Global gene expression profiling of pancreatic islets in mice during streptozotocin-induced β-cell damage and pancreatic Glp-1 gene therapy.
Tonne JM; Sakuma T; Deeds MC; Munoz-Gomez M; Barry MA; Kudva YC; Ikeda Y
Dis Model Mech; 2013 Sep; 6(5):1236-45. PubMed ID: 23828045
[TBL] [Abstract][Full Text] [Related]
18. Activation of ACE2/angiotensin (1-7) attenuates pancreatic β cell dedifferentiation in a high-fat-diet mouse model.
Xuan X; Gao F; Ma X; Huang C; Wang Y; Deng H; Wang S; Li W; Yuan L
Metabolism; 2018 Apr; 81():83-96. PubMed ID: 29225087
[TBL] [Abstract][Full Text] [Related]
19. HM-Chromanone Alleviates Hyperglycemia by Protecting Pancreatic Islet Cells in Streptozotocin-Induced Diabetic Mice.
Park JE; Han JS
J Med Food; 2023 Jun; 26(6):357-367. PubMed ID: 37083465
[TBL] [Abstract][Full Text] [Related]
20. Streptozotocin (STZ) mediates acute upregulation of serum and pancreatic osteopontin (OPN): a novel islet-protective effect of OPN through inhibition of STZ-induced nitric oxide production.
Katakam AK; Chipitsyna G; Gong Q; Vancha AR; Gabbeta J; Arafat HA
J Endocrinol; 2005 Nov; 187(2):237-47. PubMed ID: 16293771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
